Stem cell transplantation safe for patients with HIV-associated lymphoma
Stem cell transplantation safe for patients with HIV-associated lymphoma
Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study
Post-transplant survival boosted by brentuximab vedotin in lymphoma
Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study
ecancermedicalscience editor's choice for November 2014
New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion
Potential role of blood testing for microRNA profiles in paediatric cancers
Cancer genomics and pancreatic cancer
Fly models and genome sequencing
Prof Laskey receives Lifetime Achievement Prize
Comment: NCRI 2014 conference – Highlights and the future
Malignant brain tumours and the role of genetically engineered mice models